| January 23, 2008 |
| February 5, 2008 |
| July 2007 |
| January 2009 (final data collection date for primary outcome measure) |
| description of osteoprotegerin levels according to chronic renal failure progression [ Time Frame: inclusion ] [ Designated as safety issue: No ] |
| Same as current |
| Complete list of historical versions of study NCT00608998 on ClinicalTrials.gov Archive Site |
- calcium score description according to chronic renal failure progression [ Time Frame: inclusion ] [ Designated as safety issue: No ]
- osteoprotegerin description according to calcium score [ Time Frame: inclusion ] [ Designated as safety issue: No ]
- relationship between cardiovascular risk factors and calcium score [ Time Frame: inclusion ] [ Designated as safety issue: No ]
- relationship between cardiovascular risk factors and cardiovascular disease [ Time Frame: inclusion ] [ Designated as safety issue: No ]
|
| Same as current |
| |
| Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression |
| Vascular Risk Factors and Coronary Calcifications in Chronic Renal Failure Patients: Identification of Specific Factors Linked to Renal Failure Progression |
The aim of this study is to appreciate the influence of renal failure progression on vasculopathy (coronary calcifications and left ventricular hypertrophy) and cardiovascular risk factors. |
The aim of this study is to appreciate the relationship between:
- extension of coronary calcifications and chronic renal failure progression
- extension of coronary calcifications and levels of osteoprotegerin (bone disease marker)
- cardiovascular risk factors and coronary calcifications
- cardiovascular risk factors and existence of cardiovascular diseases
|
| |
| Observational |
| Case-Only, Cross-Sectional |
| Chronic Renal Failure |
| |
| |
| |
| |
| Recruiting |
| 120 |
| August 2010 |
| January 2009 (final data collection date for primary outcome measure) |
Inclusion Criteria:
Exclusion Criteria:
- Chronic renal failure patient requiring dialysis therapy
|
| Both |
| 18 Years to 90 Years |
| No |
|
|
| France |
| |
| NCT00608998 |
| Prof Bernard CANAUD, Centre Hospitalier Universitaire Montpellier France |
| UF 7853, PHRC regional 2005, CHU Montpellier, France |
| University Hospital, Montpellier |
- CHU Lapeyronie MONTPELLIER
- CHU Arnaud de Villeneuve MONTPELLIER
|
| Principal Investigator: |
Bernard CANAUD, Pr |
CHU Lapeyronie Montpellier France |
|
| Study Chair: |
Jean-Paul CRISTOL, Pr |
CHU Lapeyronie Montpellier France |
|
| Study Chair: |
Hélène VERNHET, Pr |
CHU Arnaud de Villeneuve Montpellier France |
|
| Study Chair: |
Kada KLOUCHE, Dr |
CHU Lapeyronie Montpellier France |
|
| Study Chair: |
Hélène LERAY-MORAGUES, Dr |
CHU Lapeyronie Montpellier France |
|
|
| University Hospital, Montpellier |
| January 2008 |